Sex steroids are crucial regulators of sexual differentiation and the proper development of secondary sex characteristics and patterns of sexual behavior. Since Leydig cells are the primary major producers of these steroid hormones, maintenance of the normal functions of these cells determines the reproductive capacity and fertility of males. The present minireview discusses recent findings concerning endocrine and paracrine regulation of the proliferation, differentiation and involution of human Leydig cells. The physiology and function of the two distinct fetal and adult populations of human Leydig cells are described, with particular focus on the paracrine environment that triggers their differentiation and functional maturation. The roles of established and more recently discovered paracrine regulators of this maturation, including insulin-like factor 3, platelet-derived growth factor-α, desert hedgehog, ghrelin and leptin are considered. A brief description of the origin, ontogenesis and functional markers of human fetal and adult Leydig cells is presented.

1.
Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonca BB, Elliston KO, Wilson JD, Russell DW, Andersson S: Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet 1994;7:34–39.
2.
Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ, Parker KL: Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci USA 1997;94:11540–11545.
3.
Forest MG, Sizonenko PC, Cathiard AM, Bertrand J: Hypophyso-gonadal function in humans during the first year of life. 1. Evidence for testicular activity in early infancy. J Clin Invest 1974;53:819–828.
4.
Pelliniemi LJ, Niei M: Fine structure of the human foetal testis. I. The interstitial tissue. Z Zellforsch Mikrosk Anat 1969;99:507–522.
5.
Codesal J, Regadera J, Nistal M, Regadera-Sejas J, Paniagua R: Involution of human fetal Leydig cells: an immunohistochemical, ultrastructural and quantitative study. J Anat 1990;172:103–114.
6.
Habert R, Lejeune H, Saez JM: Origin, differentiation and regulation of fetal and adult Leydig cells. Mol Cell Endocrinol 2001;179:47–74.
7.
O’Shaughnessy PJ, Baker PJ, Johnston H: The foetal Leydig cell – differentiation, function and regulation. Int J Androl 2006;29:90–95; discussion 105–108.
8.
Merke DP, Bornstein SR, Avila NA, Chrousos GP: NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med 2002;136:320–334.
9.
Domenice S, Latronico AC, Brito VN, Arnhold IJ, Kok F, Mendonca BB: Adrenocorticotropin-dependent precocious puberty of testicular origin in a boy with X-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene. J Clin Endocrinol Metab 2001;86:4068–4071.
10.
Tapanainen J, Kellokumpu-Lehtinen P, Pelliniemi L, Huhtaniemi I: Age-related changes in endogenous steroids of human fetal testis during early and midpregnancy. J Clin Endocrinol Metab 1981;52:98–102.
11.
Lambrot R, Coffigny H, Pairault C, Donnadieu AC, Frydman R, Habert R, Rouiller- Fabre V: Use of organ culture to study the human fetal testis development: effect of retinoic acid. J Clin Endocrinol Metab 2006;91:2696–2703.
12.
Rabinovici J, Jaffe RB: Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr Rev 1990;11:532–557.
13.
Sultan C, Paris F, Terouanne B, Balaguer P, Georget V, Poujol N, Jeandel C, Lumbroso S, Nicolas JC: Disorders linked to insufficient androgen action in male children. Hum Reprod Update 2001;7:314–322.
14.
Kremer H, Kraaij R, Toledo SP, et al: Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 1995;9:160–164.
15.
Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF, Jameson JL: Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Med 1992;326:179–183.
16.
Haider SG: Cell biology of Leydig cells in the testis. Int Rev Cytol 2004;233:181–241.
17.
Habert R, Picon R: Control of testicular steroidogenesis in foetal rat: effect of decapitation on testosterone and plasma luteinizing hormone-like activity. Acta Endocrinol (Copenh) 1982;99:466–473.
18.
Gautier C, Levacher C, Saez JM, Habert R: Expression and regulation of transforming growth factor beta1 mRNA and protein in rat fetal testis in vitro. Biochem Biophys Res Commun 1997;236:135–139.
19.
Rouiller-Fabre V, Carmona S, Merhi RA, Cate R, Habert R, Vigier B: Effect of anti-Mullerian hormone on Sertoli and Leydig cell functions in fetal and immature rats. Endocrinology 1998;139:1213–1220.
20.
Canto P, Vilchis F, Soderlund D, Reyes E, Mendez JP: A heterozygous mutation in the desert hedgehog gene in patients with mixed gonadal dysgenesis. Mol Hum Reprod 2005;11:833–836.
21.
Fowler PA, Cassie S, Rhind SM, Brewer MJ, Collinson JM, Lea RG, Baker PJ, Bhattacharya S, O’Shaughnessy PJ: Maternal smoking during pregnancy specifically reduces human fetal desert hedgehog gene expression during testis development. J Clin Endocrinol Metab 2008;93:619–626.
22.
Yao HH, Whoriskey W, Capel B: Desert Hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis. Genes Dev 2002;16:1433–1440.
23.
Park SY, Tong M, Jameson JL: Distinct roles for steroidogenic factor 1 and desert hedgehog pathways in fetal and adult Leydig cell development. Endocrinology 2007;148:3704–3710.
24.
Basciani S, Mariani S, Arizzi M, Ulisse S, Rucci N, Jannini EA, Della Rocca C, Manicone A, Carani C, Spera G, Gnessi L: Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and -beta during human testicular development and disease. J Clin Endocrinol Metab 2002;87:2310–2309.
25.
Gnessi L, Basciani S, Mariani S, Arizzi M, Spera G, Wang C, Bondjers C, Karlsson L, Betsholtz C: Leydig cell loss and spermatogenic arrest in platelet-derived growth factor (PDGF)-A-deficient mice. J Cell Biol 2000;149:1019–1026.
26.
Ketola I, Pentikainen V, Vaskivuo T, Ilvesmaki V, Herva R, Dunkel L, Tapanainen JS, Toppari J, Heikinheimo M: Expression of transcription factor GATA-4 during human testicular development and disease. J Clin Endocrinol Metab 2000;85:3925–3931.
27.
Bielinska M, Seehra A, Toppari J, Heikinheimo M, Wilson DB: GATA-4 is required for sex steroidogenic cell development in the fetal mouse. Dev Dyn 2007;236:203–213.
28.
Rouiller-Fabre V, Lecref L, Gautier C, Saez JM, Habert R: Expression and effect of insulin-like growth factor I on rat fetal Leydig cell function and differentiation. Endocrinology 1998;139:2926–2934.
29.
Berensztein EB, Baquedano MS, Pepe CM, Costanzo M, Saraco NI, Ponzio R, Rivarola MA, Belgorosky A: Role of IGFs and insulin in the human testis during postnatal activation: differentiation of steroidogenic cells. Pediatr Res 2008;63:662–666.
30.
Laron Z: Laron-type dwarfism (hereditary somatomedin deficiency): a review. Ergeb Inn Med Kinderheilkd 1984;51:117–150.
31.
Colon E, Svechnikov KV, Carlsson-Skwirut C, Bang P, Soder O: Stimulation of steroidogenesis in immature rat Leydig cells evoked by interleukin-1alpha is potentiated by growth hormone and insulin-like growth factors. Endocrinology 2005;146:221–230.
32.
Colon E, Zaman F, Axelson M, Larsson O, Carlsson-Skwirut C, Svechnikov KV, Soder O: Insulin-like growth factor-I is an important antiapoptotic factor for rat leydig cells during postnatal development. Endocrinology 2007;148:128–139.
33.
Saez JM: Leydig cells: endocrine, paracrine, and autocrine regulation. Endocr Rev 1994;15:574–626.
34.
Prince FP: The triphasic nature of Leydig cell development in humans, and comments on nomenclature. J Endocrinol 2001;168:213–216.
35.
Reyes FI, Boroditsky RS, Winter JS, Faiman C: Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations. J Clin Endocrinol Metab 1974;38:612–617.
36.
Forest MG, Cathiard AM, Bertrand JA: Evidence of testicular activity in early infancy. J Clin Endocrinol Metab 1973;37:148–151.
37.
Prince FP: Ultrastructure of immature Leydig cells in the human prepubertal testis. Anat Rec 1984;209:165–176.
38.
Berensztein E, Belgorosky A, de Davila MR, Rivarola MA: Basal testosterone secretion and response to human luteinizing, follicle-stimulating, and growth hormones in culture of cells isolated from testes of infants and children. Pediatr Res 1995;38:592–597.
39.
Mann DR, Fraser HM: The neonatal period: a critical interval in male primate development. J Endocrinol 1996;149:191–197.
40.
Winter JS, Hughes IA, Reyes FI, Faiman C: Pituitary-gonadal relations in infancy. 2. Patterns of serum gonadal steroid concentrations in man from birth to two years of age. J Clin Endocrinol Metab 1976;42:679–686.
41.
Prince FP, Mann DR, Fraser HM: Blockade of the hypothalamic-pituitary-testicular axis with a GnRH antagonist in the neonatal marmoset monkey: changes in Leydig cell ultrastructure. Tissue Cell 1998;30:651–661.
42.
Lunn SF, Recio R, Morris K, Fraser HM: Blockade of the neonatal rise in testosterone by a gonadotrophin-releasing hormone antagonist: effects on timing of puberty and sexual behaviour in the male marmoset monkey. J Endocrinol 1994;141:439–447.
43.
Chemes HE, Gottlieb SE, Pasqualini T, Domenichini E, Rivarola MA, Bergada C: Response to acute hCG stimulation and steroidogenic potential of Leydig cell fibroblastic precursors in humans. J Androl 1985;6:102–112.
44.
Rey RA, Nagle CA, Chemes H: Morphometric study of the testicular interstitial tissue of the monkey Cebus apella during postnatal development. Tissue Cell 1996;28:31–42.
45.
Chemes H, Cigorraga S, Bergada C, Schteingart H, Rey R, Pellizzari E: Isolation of human Leydig cell mesenchymal precursors from patients with the androgen insensitivity syndrome: testosterone production and response to human chorionic gonadotropin stimulation in culture. Biol Reprod 1992;46:793–801.
46.
Ge RS, Dong Q, Sottas CM, Papadopoulos V, Zirkin BR, Hardy MP: In search of rat stem Leydig cells: identification, isolation, and lineage-specific development. Proc Natl Acad Sci USA 2006;103:2719–2724.
47.
Teerds KJ, De Rooij DG, Rommerts FF, Wensing CJ: The regulation of the proliferation and differentiation of rat Leydig cell precursor cells after EDS administration or daily HCG treatment. J Androl 1988;9:343–351.
48.
Davidoff MS, Middendorff R, Enikolopov G, Riethmacher D, Holstein AF, Muller D: Progenitor cells of the testosterone-producing Leydig cells revealed. J Cell Biol 2004;167:935–944.
49.
Jackson AE, O’Leary PC, Ayers MM, de Kretser DM: The effects of ethylene dimethane sulphonate (EDS) on rat Leydig cells: evidence to support a connective tissue origin of Leydig cells. Biol Reprod 1986;35:425–437.
50.
Davidoff MS, Schulze W, Middendorff R, Holstein AF: The Leydig cell of the human testis – a new member of the diffuse neuroendocrine system. Cell Tissue Res 1993;271:429–439.
51.
Davidoff MS, Middendorff R, Kofuncu E, Muller D, Jezek D, Holstein AF: Leydig cells of the human testis possess astrocyte and oligodendrocyte marker molecules. Acta Histochem 2002;104:39–49.
52.
Qin J, Tsai MJ, Tsai SY: Essential roles of COUP-TFII in Leydig cell differentiation and male fertility. PLoS One 2008;3:e3285.
53.
Soriano-Guillen L, Mitchell V, Carel JC, Barbet P, Roger M, Lahlou N: Activating mutations in the luteinizing hormone receptor gene: a human model of non-follicle-stimulating hormone-dependent inhibin production and germ cell maturation. J Clin Endocrinol Metab 2006;91:3041–3047.
54.
De La Balze FA, Mancini RE, Bur GE, Irazu J: Morphologic and histochemical changes produced by estrogens on adult human testes. Fertil Steril 1954;5:421–436.
55.
Dym M, Raj HG: Response of adult rat Sertoli cells and Leydig cells to depletion of luteinizing hormone and testosterone. Biol Reprod 1977;17:676–696.
56.
Ivell R, Balvers M, Domagalski R, Ungefroren H, Hunt N, Schulze W: Relaxin-like factor: a highly specific and constitutive new marker for Leydig cells in the human testis. Mol Hum Reprod 1997;3:459–466.
57.
Foresta C, Bettella A, Vinanzi C, Dabrilli P, Meriggiola MC, Garolla A, Ferlin A: A novel circulating hormone of testis origin in humans. J Clin Endocrinol Metab 2004;89:5952–5958.
58.
Anand-Ivell R, Wohlgemuth J, Haren MT, Hope PJ, Hatzinikolas G, Wittert G, Ivell R: Peripheral INSL3 concentrations decline with age in a large population of Australian men. Int J Androl 2006;29:618–626.
59.
Wikstrom AM, Bay K, Hero M, Andersson AM, Dunkel L: Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome. J Clin Endocrinol Metab 2006;91:4705–4708.
60.
Lague E, Tremblay JJ: Antagonistic effects of testosterone and the endocrine disruptor mono-(2-ethylhexyl) phthalate on INSL3 transcription in Leydig cells. Endocrinology 2008;149:4688–4694.
61.
Tremblay JJ, Robert NM, Lague E: Nuclear receptors, testosterone, and posttranslational modifications in human INSL3 promoter activity in testicular Leydig cells. Ann NY Acad Sci 2009;1160:205–212.
62.
Toshinai K, Mondal MS, Nakazato M, Date Y, Murakami N, Kojima M, Kangawa K, Matsukura S: Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 2001;281:1220–1225.
63.
Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herington AC, Morales C, Pinilla L, Paniagua R, Nistal M, Casanueva FF, Aguilar E, Dieguez C, Tena-Sempere M: Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab 2004;89:400–409.
64.
Tena-Sempere M, Barreiro ML, Gonzalez LC, Gaytan F, Zhang FP, Caminos JE, Pinilla L, Casanueva FF, Dieguez C, Aguilar E: Novel expression and functional role of ghrelin in rat testis. Endocrinology 2002;143:717–725.
65.
Barreiro ML, Gaytan F, Caminos JE, Pinilla L, Casanueva FF, Aguilar E, Dieguez C, Tena-Sempere M: Cellular location and hormonal regulation of ghrelin expression in rat testis. Biol Reprod 2002;67:1768–1776.
66.
Ishikawa T, Fujioka H, Ishimura T, Takenaka A, Fujisawa M: Ghrelin expression in human testis and serum testosterone level. J Androl 2007;28:320–324.
67.
Yan W, Linderborg J, Suominen J, Toppari J: Stage-specific regulation of stem cell factor gene expression in the rat seminiferous epithelium. Endocrinology 1999;140:1499–1504.
68.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–432.
69.
Caprio M, Fabbrini E, Isidori AM, Aversa A, Fabbri A: Leptin in reproduction. Trends Endocrinol Metab 2001;12:65–72.
70.
Caprio M, Isidori AM, Carta AR, Moretti C, Dufau ML, Fabbri A: Expression of functional leptin receptors in rodent Leydig cells. Endocrinology 1999;140:4939–4947.
71.
Tena-Sempere M, Manna PR, Zhang FP, Pinilla L, Gonzalez LC, Dieguez C, Huhtaniemi I, Aguilar E: Molecular mechanisms of leptin action in adult rat testis: potential targets for leptin-induced inhibition of steroidogenesis and pattern of leptin receptor messenger ribonucleic acid expression. J Endocrinol 2001;170:413–423.
72.
Tchernof A, Despres JP, Belanger A, Dupont A, Prud’homme D, Moorjani S, Lupien PJ, Labrie F: Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism 1995;44:513–519.
73.
Isidori AM, Caprio M, Strollo F, Moretti C, Frajese G, Isidori A, Fabbri A: Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999;84:3673–3680.
74.
Ishikawa T, Fujioka H, Ishimura T, Takenaka A, Fujisawa M: Expression of leptin and leptin receptor in the testis of fertile and infertile patients. Andrologia 2007;39:22–27.
75.
Svechnikov K, Supornsilchai V, Strand ML, Wahlgren A, Seidlova-Wuttke D, Wuttke W, Soder O: Influence of long-term dietary administration of procymidone, a fungicide with anti-androgenic effects, or the phytoestrogen genistein to rats on the pituitary-gonadal axis and Leydig cell steroidogenesis. J Endocrinol 2005;187:117–124.
76.
Svechnikov K, Svechnikova I, Soder O: Inhibitory effects of mono-ethylhexyl phthalate on steroidogenesis in immature and adult rat Leydig cells in vitro. Reprod Toxicol 2008;25:485–490.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.